PURPOSE: This study evaluated the relationship between pain and depressive symptoms through pain self-efficacy and pain catastrophizing in breast cancer patients with pain. DESIGN: Secondary analysis of a randomized trial investigating a cognitive-behavioral pain management protocol. SAMPLE: Females (N = 327) with stage I-III breast cancer and report of at least moderate pain. METHODS: Pain severity, pain self-efficacy, pain catastrophizing, and depressive symptoms were measured. The proposed model was assessed using structural equation modeling. RESULTS: Higher pain severity was significantly related to lower pain self-efficacy and higher pain catastrophizing. Lower pain self-efficacy and higher pain catastrophizing were significantly related to more depressive symptoms. Higher pain severity was significantly associated with more depressive symptoms through lower pain self-efficacy and higher pain catastrophizing. The association between pain severity and depressive symptoms was not significant when specified as a direct effect. CONCLUSION: Pain severity related to depressive symptoms in breast cancer patients via pain self-efficacy and pain catastrophizing. IMPLICATIONS FOR PSYCHOSOCIAL PROVIDERS: Measurement of pain self-efficacy and pain catastrophizing should be incorporated into comprehensive pain assessments for women with breast cancer, as these variables may be relevant therapeutic targets. Psychosocial symptom management interventions should include strategies that increase pain self-efficacy and decrease pain catastrophizing because these pain-related cognitive variables appear to drive the relationship between pain severity and depressive symptoms.
PURPOSE: This study evaluated the relationship between pain and depressive symptoms through pain self-efficacy and pain catastrophizing in breast cancer patients with pain. DESIGN: Secondary analysis of a randomized trial investigating a cognitive-behavioral pain management protocol. SAMPLE: Females (N = 327) with stage I-III breast cancer and report of at least moderate pain. METHODS: Pain severity, pain self-efficacy, pain catastrophizing, and depressive symptoms were measured. The proposed model was assessed using structural equation modeling. RESULTS: Higher pain severity was significantly related to lower pain self-efficacy and higher pain catastrophizing. Lower pain self-efficacy and higher pain catastrophizing were significantly related to more depressive symptoms. Higher pain severity was significantly associated with more depressive symptoms through lower pain self-efficacy and higher pain catastrophizing. The association between pain severity and depressive symptoms was not significant when specified as a direct effect. CONCLUSION: Pain severity related to depressive symptoms in breast cancer patients via pain self-efficacy and pain catastrophizing. IMPLICATIONS FOR PSYCHOSOCIAL PROVIDERS: Measurement of pain self-efficacy and pain catastrophizing should be incorporated into comprehensive pain assessments for women with breast cancer, as these variables may be relevant therapeutic targets. Psychosocial symptom management interventions should include strategies that increase pain self-efficacy and decrease pain catastrophizing because these pain-related cognitive variables appear to drive the relationship between pain severity and depressive symptoms.
Entities:
Keywords:
Breast cancer; depression; pain catastrophizing; pain self-efficacy; pain severity
Authors: Dana H Bovbjerg; Francis J Keefe; Mary S Soo; Jessica Manculich; Alyssa Van Denburg; Margarita L Zuley; Gretchen M Ahrendt; Celette S Skinner; Sara N Edmond; Rebecca A Shelby Journal: Acta Oncol Date: 2019-02-12 Impact factor: 4.089
Authors: Carol E DeSantis; Jiemin Ma; Mia M Gaudet; Lisa A Newman; Kimberly D Miller; Ann Goding Sauer; Ahmedin Jemal; Rebecca L Siegel Journal: CA Cancer J Clin Date: 2019-10-02 Impact factor: 508.702
Authors: Sarah A Kelleher; Hannah M Fisher; Joseph G Winger; Tamara J Somers; Hope E Uronis; Arianna N Wright; Francis J Keefe Journal: Support Care Cancer Date: 2021-03-08 Impact factor: 3.603
Authors: Dennis C Turk; Robert H Dworkin; Robert R Allen; Nicholas Bellamy; Nancy Brandenburg; Daniel B Carr; Charles Cleeland; Raymond Dionne; John T Farrar; Bradley S Galer; David J Hewitt; Alejandro R Jadad; Nathaniel P Katz; Lynn D Kramer; Donald C Manning; Cynthia G McCormick; Michael P McDermott; Patrick McGrath; Steve Quessy; Bob A Rappaport; James P Robinson; Mike A Royal; Lee Simon; Joseph W Stauffer; Wendy Stein; Jane Tollett; James Witter Journal: Pain Date: 2003-12 Impact factor: 6.961
Authors: Tamara J Somers; Francis J Keefe; Jennifer J Pells; Kim E Dixon; Sandra J Waters; Paul A Riordan; James A Blumenthal; Daphne C McKee; Lara LaCaille; Jessica M Tucker; Daniel Schmitt; David S Caldwell; Virginia B Kraus; Ershela L Sims; Rebecca A Shelby; John R Rice Journal: J Pain Symptom Manage Date: 2008-11-28 Impact factor: 3.612
Authors: Alyssa N Van Denburg; Rebecca A Shelby; David S Caldwell; Madeline L O'Sullivan; Francis J Keefe Journal: J Pain Date: 2018-04-06 Impact factor: 5.820
Authors: Katie Wang; Caitlin Yee; Samantha Tam; Leah Drost; Stephanie Chan; Pearl Zaki; Victoria Rico; Krista Ariello; Mark Dasios; Henry Lam; Carlo DeAngelis; Edward Chow Journal: Breast Date: 2018-09-04 Impact factor: 4.380
Authors: C Foster; M Breckons; P Cotterell; D Barbosa; L Calman; J Corner; D Fenlon; R Foster; C Grimmett; A Richardson; P W Smith Journal: J Cancer Surviv Date: 2014-07-16 Impact factor: 4.442